FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Susan Hilsenbeck

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Physiology

Co-author Network

Publications

TOP 3
Erik M Wolfswinkel; Susan G Hilsenbeck; Santiago N Lopez; Sahar Qashqai; Mothaffar F Rimawi; Tao Wang; William M Weathers; Lior Heller
Predictors of post-mastectomy reconstruction in an underserved population.
Mothaffar F Rimawi; Angel A Rodriguez; Rachel Schiff; Tao Wang; Andres Forero; Matthew P Goetz; Carolina Gutierrez; Susan G Hilsenbeck; Ingrid A Mayer; Rita Nanda; C Kent Osborne; Anne C Pavlick; Jenny C Chang
Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer: TBCRC 006.
Brian York; Suoling Zhou; James R Bain; Atul R Chopra; Susan G Hilsenbeck; Olga Ilkayeva; Jean-Francois Louet; Christopher B Newgard; Erin L Reineke; Jørn V Sagen; Robert D Stevens; Anna Tsimelzon; Brett R Wenner; Jianming Xu; Bert W O'Malley
Research resource: tissue- and pathway-specific metabolomic profiles of the steroid receptor coactivator (SRC) family.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Susan Hilsenbeck (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Erik M Wolfswinkel; Susan G Hilsenbeck; Santiago N Lopez; Sahar Qashqai; Mothaffar F Rimawi; Tao Wang; William M Weathers; Lior Heller
Predictors of post-mastectomy reconstruction in an underserved population.
Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2013;66(6):763-9.
2013: Mothaffar F Rimawi; Angel A Rodriguez; Rachel Schiff; Tao Wang; Andres Forero; Matthew P Goetz; Carolina Gutierrez; Susan G Hilsenbeck; Ingrid A Mayer; Rita Nanda; C Kent Osborne; Anne C Pavlick; Jenny C Chang
Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer: TBCRC 006.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(14):1726-31.
2013: Brian York; Suoling Zhou; James R Bain; Atul R Chopra; Susan G Hilsenbeck; Olga Ilkayeva; Jean-Francois Louet; Christopher B Newgard; Erin L Reineke; Jørn V Sagen; Robert D Stevens; Anna Tsimelzon; Brett R Wenner; Jianming Xu; Bert W O'Malley
Research resource: tissue- and pathway-specific metabolomic profiles of the steroid receptor coactivator (SRC) family.
Molecular endocrinology (Baltimore, Md.) 2013;27(2):366-80.
2012: Luca Malorni; C Kent Osborne; M F Rimawi; P B Shetty; C De Angelis; Sabino De Placido; Richard M Elledge; Susan G Hilsenbeck; Grazia Arpino
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up.
Breast cancer research and treatment 2012;136(3):795-804.
2012: Carolyn L Smith; Meng-Fen Wu; Margaret C Pace; Vaishali Chaubal; Dean P Edwards; M Carolina Gutiérrez; Ryan Hartmaier; Susan G Hilsenbeck; Shiming Jiang; Ilenia Migliaccio; Steffi Oesterreich
Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence.
Breast cancer research and treatment 2012;136(1):253-65.
2012: Jasmina Z Cerne; Susan G Hilsenbeck; Jaroslav Jelinek; Steffi Oesterreich; Tao Wang; Lin Zong; Sean E McGuire
BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients.
Breast cancer research and treatment 2012;135(1):135-43.
2012: William E Fisher; Susan G Hilsenbeck; Sally E Hodges; Meng-Fen Wu; F Charles Brunicardi
Assessment of the learning curve for pancreaticoduodenectomy.
American journal of surgery 2012;203(6):684-90.
2012: Jason I Herschkowitz; Susan G Hilsenbeck; Jana Knezevic; Daniel Medina; George Murrow; Charles M Perou; Melissa A Troester; Jerry Usary; Mei Zhang; Wei Zhao; David Darr; David Edwards; Stephanie B Greene; Jeffrey M Rosen
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(8):2778-83.
2012: Mothaffar Rimawi; Susan G Hilsenbeck
Making sense of clinical trial data: is inverse probability of censoring weighted analysis the answer to crossover bias?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(4):453-8.
2012: Angelo J Casa; Chad J Creighton; Susan G Hilsenbeck; Hee-Tae Kim; Isere Kuiatse; Zawaunyka Lazard; Simeen Malik; Steffi Oesterreich; Adam S Potter; Anna Tsimelzon; Powell H Brown; Adrian V Lee
Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth.
Breast cancer research and treatment 2012;132(1):61-73.
2012: Jessica D Kessler; Mamie Z Li; Anthony C Liang; Ji Luo; Kristen L Meerbrey; C Kent Osborne; Mitchell Rao; Rachel Schiff; Michael R Schlabach; Earlene M Schmitt; Chad A Shaw; Samuel O Skinner; Nicole L Solimini; Tingting Sun; Ronald J Bernardi; Chad J Creighton; Rocio Dominguez-Vidana; Stephen J Elledge; Ido Golding; Zachary Conrad Hartman; Susan G Hilsenbeck; Tiffany Hsu; Kristopher T Kahle; Qikai Xu; Bing Yu; Peng Yu; Thomas F Westbrook
A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.
Science (New York, N.Y.) 2012;335(6066):348-53.
2012: Bhuvanesh Dave; Lacey E Dobrolecki; Susan G Hilsenbeck; Melissa D Landis; Dan Liu; David J Tweardy; Thomas F Westbrook; Meng-Fen Wu; Xiaomei Zhang; Jenny C Chang; Michael Lewis
Selective small molecule Stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft model.
PloS one 2012;7(8):e30207.
2011: Suleiman Massarweh; Mothaffar Rimawi; Krystal Sexton; Yee-Lu Tham; Anna Tsimelzon; Heidi Weiss; Amanda Beyer; Wei Yen Cai; Suzanne Fuqua; Susan G Hilsenbeck; Jian Huang; Richard M Elledge
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.
Breast cancer research and treatment 2011;129(3):819-27.
2011: S U Dhar; Susan G Hilsenbeck; B Parks; S A Staggs; T Wang; H Paul Cooper; Sharon E Plon
Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers.
Breast cancer research and treatment 2011;129(1):221-7.
2011: Thushangi N Pathiraja; Priya B Shetty; Ryan Hartmaier; Rong He; Susan G Hilsenbeck; Jean-Pierre J Issa; Jaroslav Jelinek; Astrid L Margossian; Steffi Oesterreich
Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(12):4177-86.
2011: Beate C Litzenburger; Chad J Creighton; Anna Tsimelzon; Bonita T Chan; Susan G Hilsenbeck; Tao Wang; Joan M Carboni; Marco M Gottardis; Fei Huang; Jenny C Chang; Michael Lewis; Mothaffar F Rimawi; Adrian V Lee
High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(8):2314-27.
2011: Ines Barone; Lauren Brusco; Guowei Gu; Jennifer Selever; Amanda Beyer; Kyle R Covington; Anna Tsimelzon; Tao Wang; Susan G Hilsenbeck; Gary C Chamness; Sebastiano Andò; Suzanne A W Fuqua
Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.
Journal of the National Cancer Institute 2011;103(7):538-52.
2011: Mothaffar F Rimawi; Lisa Wiechmann; Yen-Chao Wang; Catherine Huang; Ilenia Migliaccio; Meng-Fen Wu; Carolina Gutierrez; Susan G Hilsenbeck; Grazia Arpino; Suleiman Massarweh; Robin Ward; Robert Soliz; C Kent Osborne; Rachel Schiff
Reduced dose and intermittent treatment with lapatinib and trastuzumab for potent blockade of the HER pathway in HER2/neu-overexpressing breast tumor xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(6):1351-61.
2011: Tingting Sun; Nicola Aceto; Kristen L Meerbrey; Jessica D Kessler; Chunshui Zhou; Ilenia Migliaccio; Don X Nguyen; Natalya N Pavlova; Maria Botero; Jian Huang; Ronald J Bernardi; Earlene Schmitt; Guang Hu; Mamie Z Li; Noah Dephoure; Steven P Gygi; Mitchell Rao; Chad J Creighton; Susan G Hilsenbeck; Chad A Shaw; Donna Muzny; Richard A Gibbs; David A Wheeler; C Kent Osborne; Rachel Schiff; Mohamed Bentires-Alj; Stephen J Elledge; Thomas F Westbrook
Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.
Cell 2011;144(5):703-18.
2011: Bhuvanesh Dave; Ilenia Migliaccio; M Carolina Gutierrez; Meng-Fen Wu; Gary C Chamness; Helen Wong; Archana Narasanna; Anindita Chakrabarty; Susan G Hilsenbeck; Jian Huang; Mothaffar Rimawi; Rachel Schiff; Carlos Arteaga; C Kent Osborne; Jenny C Chang
Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2-overexpressing locally advanced breast cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(2):166-73.
2011: Yen-Chao Wang; Robin M Ward; Maria F Botero; Gary C Chamness; Xiaoyong Fu; Ryan Gillihan; Jun Guo; Nuala A Healy; Susan G Hilsenbeck; Gladys Morrison; C Kent Osborne; Gail Lewis Phillips; Mothaffar F Rimawi; Rachel Schiff
Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers--role of estrogen receptor and HER2 reactivation.
Breast cancer research : BCR 2011;13(6):R121.
2011: Catherine Huang; C Kent Osborne; Catherine C Park; Mothaffar F Rimawi; Mina J Bissell; Susan G Hilsenbeck; Jiang Shou; Yen-Chao Wang; Robin Ward; Rachel Schiff
β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib.
Breast cancer research : BCR 2011;13(4):R84.
2011: Robert K Dearth; Susan G Hilsenbeck; Isere Kuiatse; Lan Liao; Yu-Fen Wang; Jianming Xu; Powel H Brown; Adrian V Lee
A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis.
BMC cancer 2011;11():377.
2011: Marla H Daves; Susan G Hilsenbeck; Ching C Lau; Tsz-Kwong Man
Meta-analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors.
BMC medical genomics 2011;4():56.
2010: Chad A Hall; Runsheng Wang; Jiangyong Miao; Esther Oliva; Xiaoyun Shen; Thomas Wheeler; Susan G Hilsenbeck; Sandra Orsulic; Scott Goode
Hippo pathway effector Yap is an ovarian cancer oncogene.
Cancer research 2010;70(21):8517-25.
2010: Rachel L Atkinson; Mei Zhang; Parmeswaran Diagaradjane; Sirisha Peddibhotla; Alejandro Contreras; Susan G Hilsenbeck; Wendy A Woodward; Sunil Krishnan; Jenny C Chang; Jeffrey M Rosen
Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy.
Science translational medicine 2010;2(55):55ra79.
2010: Ilenia Migliaccio; Meng-Fen Wu; Carolina Gutierrez; Luca Malorni; Syed K Mohsin; D Craig Allred; Susan G Hilsenbeck; C Kent Osborne; Heidi Weiss; Adrian V Lee
Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer.
Breast cancer research and treatment 2010;123(3):651-60.
2010: Daniel J Moskovic; Sally E Hodges; Meng-Fen Wu; F Charles Brunicardi; Susan G Hilsenbeck; William E Fisher
Drain data to predict clinically relevant pancreatic fistula.
HPB : the official journal of the International Hepato Pancreato Biliary Association 2010;12(7):472-81.
2010: A A Rodriguez; Andreas Makris; Meng-Fen Wu; Mothaffar Rimawi; A Froehlich; B Dave; Susan G Hilsenbeck; Gary C Chamness; Michael Lewis; L E Dobrolecki; D Jain; S Sahoo; C Kent Osborne; Jenny C Chang
DNA repair signature is associated with anthracycline response in triple negative breast cancer patients.
Breast cancer research and treatment 2010;123(1):189-96.
2010: Stephanie Hammerich-Hille; Valerie J Bardout; Susan G Hilsenbeck; C Kent Osborne; Steffi Oesterreich
Low SAFB levels are associated with worse outcome in breast cancer patients.
Breast cancer research and treatment 2010;121(2):503-9.
2010: Alex D Sweeney; William E Fisher; Meng-Fen Wu; Susan G Hilsenbeck; F Charles Brunicardi
Value of pancreatic resection for cancer metastatic to the pancreas.
The Journal of surgical research 2010;160(2):268-76.
2010: Francesca De Amicis; Janagi Thirugnansampanthan; Yukun Cui; Jennifer Selever; Amanda Beyer; Irma Parra; Nancy L Weigel; Matthew H Herynk; Anna Tsimelzon; Michael Lewis; Gary C Chamness; Susan G Hilsenbeck; Sebastiano Andò; Suzanne A W Fuqua
Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells.
Breast cancer research and treatment 2010;121(1):1-11.
2010: Carlos J Pérez-Torres; Cynthia A Massaad; Susan G Hilsenbeck; Faridis Serrano; Robia Pautler
In vitro and in vivo magnetic resonance imaging (MRI) detection of GFP through magnetization transfer contrast (MTC).
NeuroImage 2010;50(2):375-82.
2010: Peter R McHenry; Jeffrey M Rosen; Megan Rybarczyk; James C Sears; Peggy Chang; Lewis A Chodosh; Edward J Gunther; Brandy M Heckman-Stoddard; Matthew P Herrick; Susan G Hilsenbeck; Tracy Vargo-Gogola
P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
Breast cancer research : BCR 2010;12(5):R73.
2010: Chad J Creighton; Xiaoyong Fu; Bryan T Hennessy; Angelo J Casa; Yiqun Zhang; Ana Maria Gonzalez-Angulo; Ana Lluch; Joe Gray; Powel H Brown; Susan G Hilsenbeck; C Kent Osborne; Gordon B Mills; Adrian V Lee; Rachel Schiff
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.
Breast cancer research : BCR 2010;12(3):R40.
2009: Lu Chen; Julie Ann Mayer; Tibor I Krisko; Corey W Speers; Tao Wang; Susan G Hilsenbeck; Powel H Brown
Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells.
Cancer research 2009;69(23):8853-61.
2009: Meng-Fen Wu; Susan G Hilsenbeck; Yee-Lu Tham; Rita Kramer; Richard M Elledge; Jenny C Chang; Lois C Friedman
The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer.
Breast cancer research and treatment 2009;118(2):369-75.
2009: Alex D Sweeney; Meng-Fen Wu; Susan G Hilsenbeck; F Charles Brunicardi; William E Fisher
Value of pancreatic resection for cancer metastatic to the pancreas.
The Journal of surgical research 2009;156(2):189-98.
2009: Chad J Creighton; X Li; Melissa Landis; J Michael Dixon; Veronique M Neumeister; Ashley Sjolund; David L Rimm; Helen Wong; Angel Rodriguez; Jason I Herschkowitz; Cheng Fan; Xiaomei Zhang; Xiaping He; Anne Pavlick; M Carolina Gutierrez; Lorna Renshaw; Alexey A Larionov; Dana Faratian; Susan G Hilsenbeck; Charles M Perou; Michael Lewis; Jeffrey M Rosen; Jenny C Chang
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(33):13820-5.
2009: Jenny C Chang; Susan G Hilsenbeck; Suzanne A W Fuqua
Pharmacogenetics of breast cancer: toward the individualization of therapy.
Cancer investigation 2009;27(7):699-703.
2009: Xiaomei Zhang; Nikesha Harrington; Ricardo C Moraes; Meng-Fen Wu; Susan G Hilsenbeck; Michael Lewis
Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo).
Breast cancer research and treatment 2009;115(3):505-21.
2009: Chad J Creighton; C Kent Osborne; Marc J van de Vijver; John A Foekens; Jan G Klijn; Hugo M Horlings; Dimitry Nuyten; Yixin Wang; Yi Zhang; Gary C Chamness; Susan G Hilsenbeck; Adrian V Lee; Rachel Schiff
Molecular profiles of progesterone receptor loss in human breast tumors.
Breast cancer research and treatment 2009;114(2):287-99.
2009: Ana Moran; Anna I Tsimelzon; Mary-Ann A Mastrangelo; Yong Wu; Bi Yu; Susan G Hilsenbeck; Valeria Poli; David Tweardy
Prevention of trauma/hemorrhagic shock-induced lung apoptosis by IL-6-mediated activation of Stat3.
Clinical and translational science 2009;2(1):41-9.
2009: Daniel Medina; Frances S Kittrell; Jamal Hill; Yun Zhang; Susan G Hilsenbeck; Reid Bissonette; Powel H Brown
Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.
Cancer prevention research (Philadelphia, Pa.) 2009;2(2):168-74.
2009: Tracy E Strecker; Qiang Shen; Yun Zhang; Jamal L Hill; Yuxin Li; Chunyu Wang; Hee-Tae Kim; Tona M Gilmer; Krystal R Sexton; Susan G Hilsenbeck; C Kent Osborne; Powel H Brown
Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice.
Journal of the National Cancer Institute 2009;101(2):107-13.
2009: Amy L McGuire; Christina M Diaz; Tao Wang; Susan G Hilsenbeck
Social networkers' attitudes toward direct-to-consumer personal genome testing.
The American journal of bioethics : AJOB 2009;9(6-7):3-10.
2009: Brandy M Heckman-Stoddard; Tracy Vargo-Gogola; Peter R McHenry; Vivian Jiang; Matthew P Herrick; Susan G Hilsenbeck; Jeffrey Settleman; Jeffrey M Rosen
Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression.
Breast cancer research : BCR 2009;11(4):R61.
2009: Scott A Ochsner; David Steffen; Susan G Hilsenbeck; Edward S Chen; Christopher Watkins; Neil J McKenna
GEMS (Gene Expression MetaSignatures), a Web resource for querying meta-analysis of expression microarray datasets: 17beta-estradiol in MCF-7 cells.
Cancer research 2009;69(1):23-6.
2008: Chad J Creighton; Suleiman Massarweh; Shixia Huang; Anna Tsimelzon; Susan G Hilsenbeck; C Kent Osborne; Jiang Shou; Luca Malorni; Rachel Schiff
Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts.
Cancer research 2008;68(18):7493-501.
2008: Chad J Creighton; Angelo Casa; Zawaunyka Lazard; Shixia Huang; Anna Tsimelzon; Susan G Hilsenbeck; C Kent Osborne; Adrian V Lee
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4078-85.
2008: Mei Zhang; Fariba Behbod; Rachel L Atkinson; Melissa D Landis; Frances S Kittrell; David Edwards; Daniel Medina; Anna Tsimelzon; Susan G Hilsenbeck; Jeffrey E Green; Aleksandra M Michalowska; Jeffrey M Rosen
Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.
Cancer research 2008;68(12):4674-82.
2008: Dhruvil Shah; William E Fisher; Sally E Hodges; Meng-Fen Wu; Susan G Hilsenbeck; F Charles Brunicardi
Preoperative prediction of complete resection in pancreatic cancer.
The Journal of surgical research 2008;147(2):216-20.
2008: Qiang Shen; Ivan P Uray; Yuxin Li; Yun Zhang; Jamal Hill; Xiao-Chun Xu; Matthew R Young; Edward J Gunther; Susan G Hilsenbeck; Nancy H Colburn; Lewis A Chodosh; Powel H Brown
Targeting the activator protein 1 transcription factor for the prevention of estrogen receptor-negative mammary tumors.
Cancer prevention research (Philadelphia, Pa.) 2008;1(1):45-55.
2008: X Li; Michael Lewis; Jian Huang; Carolina Gutierrez; C Kent Osborne; Meng-Fen Wu; Susan G Hilsenbeck; Anne Pavlick; Xiaomei Zhang; Gary C Chamness; Helen Wong; Jeffrey Rosen; Jenny C Chang
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.
Journal of the National Cancer Institute 2008;100(9):672-9.
2008: D Kay Blanchard; Priya B Shetty; Susan G Hilsenbeck; Richard M Elledge
Association of surgery with improved survival in stage IV breast cancer patients.
Annals of surgery 2008;247(5):732-8.
2008: William E Fisher; Christy Chai; Sally E Hodges; Meng-Fen Wu; Susan G Hilsenbeck; F Charles Brunicardi
Effect of BioGlue on the incidence of pancreatic fistula following pancreas resection.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2008;12(5):882-90.
2008: Jenny C Chang; Andreas Makris; M Carolina Gutierrez; Susan G Hilsenbeck; James R Hackett; Jennie Jeong; Mei-Lan Liu; Joffre Baker; Kim Clark-Langone; Frederick L Baehner; Krsytal Sexton; Syed K Mohsin; Tara Gray; Laura Alvarez; Gary C Chamness; C Kent Osborne; Steven Shak
Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients.
Breast cancer research and treatment 2008;108(2):233-40.
2008: Jeffrey A Alten; Ana Moran; Anna I Tsimelzon; Mary-Ann A Mastrangelo; Susan G Hilsenbeck; Valeria Poli; David Tweardy
Prevention of hypovolemic circulatory collapse by IL-6 activated Stat3.
PloS one 2008;3(2):e1605.
2008: James M Rae; Todd C Skaar; Susan G Hilsenbeck; Steffi Oesterreich
The role of single nucleotide polymorphisms in breast cancer metastasis.
Breast cancer research : BCR 2008;10(1):301.
2007: Yuxin Li; Yun Zhang; Jamal Hill; Qiang Shen; Heung Tae Kim; Xiaochun Xu; Susan G Hilsenbeck; Reid P Bissonnette; William W Lamph; Powel H Brown
The Rexinoid LG100268 prevents the development of preinvasive and invasive estrogen receptor negative tumors in MMTV-erbB2 mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6224-31.
2007: Richard W Yee; Harry G Sperling; Ashballa Kattek; Martin T Paukert; Kevin Dawson; Marcie Garcia; Susan G Hilsenbeck
Isolation of the ocular surface to treat dysfunctional tear syndrome associated with computer use.
The ocular surface 2007;5(4):308-15.
2007: Michele S Redell; Anna Tsimelzon; Susan G Hilsenbeck; David Tweardy
Conditional overexpression of Stat3alpha in differentiating myeloid cells results in neutrophil expansion and induces a distinct, antiapoptotic and pro-oncogenic gene expression pattern.
Journal of leukocyte biology 2007;82(4):975-85.
2007: Matthew H Herynk; Irma Parra; Yukun Cui; Amanda Beyer; Meng-Fen Wu; Susan G Hilsenbeck; Suzanne A W Fuqua
Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3235-43.
2007: Ricardo C Moraes; Xiaomei Zhang; Nikesha Harrington; Jennifer Y Fung; Meng-Fen Wu; Susan G Hilsenbeck; D Craig Allred; Michael Lewis
Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia.
Development (Cambridge, England) 2007;134(6):1231-42.
2006: Heung Tae Kim; Gu Kong; David G DeNardo; Yuxin Li; Ivan P Uray; Sunita Pal; Syed K Mohsin; Susan G Hilsenbeck; Reid P Bissonnette; William W Lamph; Karen Johnson; Powel H Brown
Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays.
Cancer research 2006;66(24):12009-18.
2006: Shixia Huang; Katrina Podsypanina; Yidong Chen; Weiyan Cai; Anna Tsimelzon; Susan G Hilsenbeck; Yi Li
Wnt-1 is dominant over neu in specifying mammary tumor expression profiles.
Technology in cancer research & treatment 2006;5(6):565-71.
2006: Xiao-Jun Ma; Susan G Hilsenbeck; Wilson Wang; Li Ding; Dennis C Sgroi; Richard A Bender; C Kent Osborne; D Craig Allred; Mark G Erlander
The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(28):4611-9.
2006: Dang M Nguyen; Kathy Sam; Anna Tsimelzon; Xiaoxian Li; Helen Wong; Syed K Mohsin; Gary M Clark; Susan G Hilsenbeck; Richard M Elledge; D Craig Allred; Peter O'Connell; Jenny C Chang
Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(17):5047-54.
2006: Suleiman Massarweh; C Kent Osborne; Shou Jiang; Alan E Wakeling; Mothaffar Rimawi; Syed K Mohsin; Susan G Hilsenbeck; Rachel Schiff
Mechanisms of tumor regression and resistance to estrogen deprivation and fulvestrant in a model of estrogen receptor-positive, HER-2/neu-positive breast cancer.
Cancer research 2006;66(16):8266-73.
2006: Yee-Lu Tham; Krystal Sexton; Rita Kramer; Susan G Hilsenbeck; Richard M Elledge
Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
Cancer 2006;107(4):696-704.
2006: Qiang Shen; Yun Zhang; Ivan P Uray; Jamal L Hill; Heung Tae Kim; Chunhua Lu; Matthew R Young; Edward J Gunther; Susan G Hilsenbeck; Lewis A Chodosh; Nancy H Colburn; Powel H Brown
The AP-1 transcription factor regulates postnatal mammary gland development.
Developmental biology 2006;295(2):589-603.
2006: Yukun Cui; Irma Parra; Mao Zhang; Susan G Hilsenbeck; Anna Tsimelzon; Toru Furukawa; Akira Horii; Zhong-Yin Zhang; Robert I Nicholson; Suzanne A W Fuqua
Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance.
Cancer research 2006;66(11):5950-9.
2006: Agathe Bourgogne; Susan G Hilsenbeck; Gary M Dunny; Barbara E Murray
Comparison of OG1RF and an isogenic fsrB deletion mutant by transcriptional analysis: the Fsr system of Enterococcus faecalis is more than the activator of gelatinase and serine protease.
Journal of bacteriology 2006;188(8):2875-84.
2006: Fariba Behbod; Wa Xian; Chad A Shaw; Susan G Hilsenbeck; Anna Tsimelzon; Jeffrey M Rosen
Transcriptional profiling of mammary gland side population cells.
Stem cells (Dayton, Ohio) 2006;24(4):1065-74.
2006: Susan G Hilsenbeck; C Kent Osborne
Is there a role for adjuvant tamoxifen in progesterone receptor-positive breast cancer? An in silico clinical trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 2):1049s-1055s.
2006: Hyun-Jung Kim; Xiaojiang Cui; Susan G Hilsenbeck; Adrian V Lee
Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 2):1013s-1018s.
2006: Steven E Come; Aman U Buzdar; James N Ingle; Carlos L Arteaga; Myles Brown; Mitch Dowsett; Susan G Hilsenbeck; Rakesh Kumar; Stephen R D Johnston; Adrian V Lee; Soonmyung Paik; Kathleen I Pritchard; Eric P Winer; Carol Hart
Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 2):997s-1000s.
2006: Susan J Cleator; Anna Tsimelzon; Alan Ashworth; Mitch Dowsett; Timothy Dexter; Trevor Powles; Susan G Hilsenbeck; Helen Wong; C Kent Osborne; Peter O'Connell; Jenny C Chang
Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (cytoxan) (AC) response and resistance.
Breast cancer research and treatment 2006;95(3):229-33.
2006: Sangjun Lee; Syed K Mohsin; Sufeng Mao; Susan G Hilsenbeck; Dan Medina; D Craig Allred
Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer.
Breast cancer research : BCR 2006;8(1):R6.
2006: Michelle D Martin; Susan G Hilsenbeck; Syed K Mohsin; Torsten A Hopp; Gary M Clark; C Kent Osborne; D Craig Allred; Peter O'Connell
Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies.
Breast cancer research and treatment 2006;95(1):7-12.
2005: Yee-Lu Tham; L Fernando Gomez; Syed K Mohsin; M Carolina Gutierrez; Heidi Weiss; Susan G Hilsenbeck; Richard M Elledge; Gary C Chamness; C Kent Osborne; D Craig Allred; Jenny C Chang
Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers.
Breast cancer research and treatment 2005;94(3):279-84.
2005: Chunhua Lu; Qiang Shen; Elizabeth DuPré; Heetae Kim; Susan G Hilsenbeck; Powel H Brown
cFos is critical for MCF-7 breast cancer cell growth.
Oncogene 2005;24(43):6516-24.
2005: Jae Wook Jeong; Kevin Y Lee; Inseok Kwak; Lisa D White; Susan G Hilsenbeck; John P Lydon; Francesco J DeMayo
Identification of murine uterine genes regulated in a ligand-dependent manner by the progesterone receptor.
Endocrinology 2005;146(8):3490-505.
2005: Grazia Arpino; Heidi L Weiss; Gary M Clark; Susan G Hilsenbeck; C Kent Osborne
Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(21):4687-94.
2005: Gu Kong; Heung Tae Kim; Kendall Wu; David G DeNardo; Susan G Hilsenbeck; Xiao-Chun Xu; William W Lamph; Reid P Bissonnette; Andrew J Dannenberg; Powel H Brown
The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention.
Cancer research 2005;65(8):3462-9.
2005: Syed K Mohsin; Heidi L Weiss; M Carolina Gutierrez; Gary C Chamness; Rachel Schiff; Michael P DiGiovanna; Chun-Xia Wang; Susan G Hilsenbeck; C Kent Osborne; D Craig Allred; Richard M Elledge; Jenny C Chang
Neoadjuvant trastuzumab induces apoptosis in primary breast cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(11):2460-8.
2005: Donna T Chen; Donald Rosenstein; Palaniappan Muthappan; Susan G Hilsenbeck; Franklin G Miller; Ezekiel J Emanuel; David Wendler
Research with stored biological samples: what do research participants want?
Archives of internal medicine 2005;165(6):652-5.
2005: Jenny C Chang; Eric Wooten; Anna Tsimelzon; Susan G Hilsenbeck; M Carolina Gutierrez; Yee-Lu Tham; Mamta Kalidas; Richard M Elledge; Syed K Mohsin; C Kent Osborne; Gary C Chamness; D Craig Allred; Michael Lewis; Helen Wong; Peter O'Connell
Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(6):1169-77.
2005: David G DeNardo; Heung Tae Kim; Susan G Hilsenbeck; Valerie Cuba; Anna Tsimelzon; Powel H Brown
Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes.
Molecular endocrinology (Baltimore, Md.) 2005;19(2):362-78.
2005: Jenny C Chang; Susan G Hilsenbeck; Suzanne A W Fuqua
The promise of microarrays in the management and treatment of breast cancer.
Breast cancer research : BCR 2005;7(3):100-4.
2005: Ismail Jatoi; Anna Tsimelzon; Heidi Weiss; Gary M Clark; Susan G Hilsenbeck
Hazard rates of recurrence following diagnosis of primary breast cancer.
Breast cancer research and treatment 2005;89(2):173-8.
2004: Mamta Kalidas; Susan G Hilsenbeck; Powel Brown
Defining the role of raloxifene for the prevention of breast cancer.
Journal of the National Cancer Institute 2004;96(23):1731-3.
2004: Suh-Chin J Lin; Kuo-Fen Lee; Alexander Nikitin; Susan G Hilsenbeck; Robert Cardiff; Aihua Li; Keon Wook Kang; Steven A Frank; Wen-Hwa Lee; Eva Y-H P Lee
Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.
Cancer research 2004;64(10):3525-32.
2004: Torsten A Hopp; Heidi L Weiss; Susan G Hilsenbeck; Yukun Cui; D Craig Allred; Kathryn B Horwitz; Suzanne A W Fuqua
Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(8):2751-60.
2004: Eun-Soo Han; Yimin Wu; Roger McCarter; James Nelson; Arlan G Richardson; Susan G Hilsenbeck
Reproducibility, sources of variability, pooling, and sample size: important considerations for the design of high-density oligonucleotide array experiments.
The journals of gerontology. Series A, Biological sciences and medical sciences 2004;59(4):306-15.
2004: Suzanne A W Fuqua; Jenny C Chang; Susan G Hilsenbeck
Genomic approaches to understanding and treating breast cancer.
Breast disease 2004;19():35-46.
2004: Melissa Drysdale; Agathe Bourgogne; Susan G Hilsenbeck; Theresa Koehler
atxA controls Bacillus anthracis capsule synthesis via acpA and a newly discovered regulator, acpB.
Journal of bacteriology 2004;186(2):307-15.
2003: Chunhua Lu; Corey Speers; Yun Zhang; Xiaochun Xu; Jamal Hill; Emily Steinbis; Joseph Celestino; Qiang Shen; Heetae Kim; Susan G Hilsenbeck; Syed K Mohsin; Alan E Wakeling; C Kent Osborne; Powel H Brown
Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors.
Journal of the National Cancer Institute 2003;95(24):1825-33.
2003: Andrea E Van Pelt; Syed K Mohsin; Richard M Elledge; Susan G Hilsenbeck; M Carolina Gutierrez; Anthony Lucci; Mamta Kalidas; Thomas S Granchi; Bradford G Scott; D Craig Allred; Jenny C Chang
Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary results.
Clinical breast cancer 2003;4(5):348-53.
2003: Jenny C Chang; Eric Wooten; Anna Tsimelzon; Susan G Hilsenbeck; M Carolina Gutierrez; Richard M Elledge; Syed K Mohsin; C Kent Osborne; Gary C Chamness; D Craig Allred; Peter O'Connell
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer.
Lancet 2003;362(9381):362-9.
2003: Qun Liu; Susan G Hilsenbeck; Yair Gazitt
Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL.
Blood 2003;101(10):4078-87.
2003: Agathe Bourgogne; Melissa Drysdale; Susan G Hilsenbeck; Scott N Peterson; Theresa Koehler
Global effects of virulence gene regulators in a Bacillus anthracis strain with both virulence plasmids.
Infection and immunity 2003;71(5):2736-43.
2003: C Kent Osborne; Valerie Bardou; Torsten A Hopp; Gary C Chamness; Susan G Hilsenbeck; Suzanne A W Fuqua; Jiemin Wong; D Craig Allred; Gary M Clark; Rachel Schiff
Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.
Journal of the National Cancer Institute 2003;95(5):353-61.
2002: Kendall Wu; Yun Zhang; Xiao-Chun Xu; Jamal Hill; Joseph Celestino; Heung Tae Kim; Syed K Mohsin; Susan G Hilsenbeck; William W Lamph; Reid Bissonette; Powel H Brown
The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice.
Cancer research 2002;62(22):6376-80.
2002: Yongmin Liu; John H Ludes-Meyers; Yun Zhang; Debbie Munoz-Medellin; Heung Tae Kim; Chunhua Lu; Gouqing Ge; Rachel Schiff; Susan G Hilsenbeck; C Kent Osborne; Powel H Brown
Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.
Oncogene 2002;21(50):7680-9.
2002: Valerie Lawrence; Susan G Hilsenbeck; Helaine Noveck; Roy M Poses; Jeffrey L Carson
Medical complications and outcomes after hip fracture repair.
Archives of internal medicine 2002;162(18):2053-7.
2002: Linda A de Graffenried; Susan G Hilsenbeck; Suzanne A W Fuqua
Sp1 is essential for estrogen receptor alpha gene transcription.
The Journal of steroid biochemistry and molecular biology 2002;82(1):7-18.
2002: Donald A Berry; Edwin S Iversen; Daniel F Gudbjartsson; Elaine H Hiller; Judy E Garber; Beth N Peshkin; Caryn Lerman; Patrice Watson; Henry T Lynch; Susan G Hilsenbeck; Wendy S Rubinstein; Kevin S Hughes; Giovanni Parmigiani
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(11):2701-12.
2002: Lakshmi Sivaraman; Jason Gay; Susan G Hilsenbeck; Harold Shine; Orla M Conneely; Daniel Medina; Bert W O'Malley
Effect of selective ablation of proliferating mammary epithelial cells on MNU induced rat mammary tumorigenesis.
Breast cancer research and treatment 2002;73(1):75-83.
2002: Kendall Wu; Heung Tae Kim; Jenny L Rodriquez; Susan G Hilsenbeck; Syed K Mohsin; Xiao-Chun Xu; William W Lamph; John Kuhn; Jeffrey E Green; Powel H Brown
Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(5):467-74.
2001: Daniel Medina; Lakshmi Sivaraman; Susan G Hilsenbeck; Orla M Conneely; Melanie R Ginger; J Rosen; B W Omalle
Mechanisms of hormonal prevention of breast cancer.
Annals of the New York Academy of Sciences 2001;952():23-35.
2001: Lakshmi Sivaraman; Susan G Hilsenbeck; Ling Zhong; Jason Gay; Orla M Conneely; Daniel Medina; Bert W O'Malley
Early exposure of the rat mammary gland to estrogen and progesterone blocks co-localization of estrogen receptor expression and proliferation.
The Journal of endocrinology 2001;171(1):75-83.
2001: J Chang; Susan G Hilsenbeck; Judy Sng; J Wong; G C Ragu
Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1739-42.
2001: John H Ludes-Meyers; Yongmin Liu; D Muñoz-Medellin; Susan G Hilsenbeck; Powel H Brown
AP-1 blockade inhibits the growth of normal and malignant breast cells.
Oncogene 2001;20(22):2771-80.
2000: Rachel Schiff; P Reddy; M Ahotupa; EB Coronado-Heinsohn; M Grim; Susan G Hilsenbeck; R Lawrence; SM Deneke; Rafael E Herrera; Gary C Chamness; Suzanne A W Fuqua; Powel H Brown; C Kent Osborne
Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo.
Journal of the National Cancer Institute 2000;92(23):1926-34.
2000: Lisa A Hammond; Susan G Hilsenbeck; S Gail Eckhardt; Jennifer Marty; Gina L Mangold; John R MacDonald; Eric K Rowinsky; Daniel Von Hoff; Steven D Weitman
Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model.
European journal of cancer (Oxford, England : 1990) 2000;36(18):2430-6.
2000: K Wu; Heung Tae Kim; J L Rodriquez; Debbie Munoz-Medellin; Syed K Mohsin; Susan G Hilsenbeck; William W Lamph; Marco Gottardis; M A Shirley; John Kuhn; Jeffrey E Green; Powel H Brown
9-cis-Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen-transgenic mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3696-704.
2000: Suzanne A W Fuqua; C Wiltschke; Q X Zhang; A Borg; C G Castles; WE Friedrichs; Torsten A Hopp; Susan G Hilsenbeck; Syed K Mohsin; Peter O'Connell; D Craig Allred
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions.
Cancer research 2000;60(15):4026-9.
2000: Steven D Weitman; H Barrera; R Moore; C Gonzalez; Jennifer Marty; Susan G Hilsenbeck; John R MacDonald; Stephen J Waters; Daniel Von Hoff
MGI 114: augmentation of antitumor activity when combined with topotecan.
Journal of pediatric hematology/oncology 2000;22(4):306-14.
2000: RICHARD ZELLARS; Susan G Hilsenbeck; Gary M Clark; D Craig Allred; Terence S Herman; Gary C Chamness; Richard M Elledge
Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1906-13.
1999: Peter O'Connell; Karl-Friedrich Fischbach; Susan G Hilsenbeck; Syed K Mohsin; Suzanne A W Fuqua; Gary M Clark; C Kent Osborne; D Craig Allred
Loss of heterozygosity at D14S62 and metastatic potential of breast cancer.
Journal of the National Cancer Institute 1999;91(16):1391-7.
1999: Ismail Jatoi; Susan G Hilsenbeck; Gary M Clark; C Kent Osborne
Significance of axillary lymph node metastasis in primary breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2334-40.
1999: Rhonda K Hansen; Irma Parra; P Lemieux; Steffi Oesterreich; Susan G Hilsenbeck; Suzanne A W Fuqua
Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells.
Breast cancer research and treatment 1999;56(2):187-96.
1999: Adrian V Lee; James G Jackson; Jennifer L Gooch; Susan G Hilsenbeck; EB Coronado-Heinsohn; C Kent Osborne; D Yee
Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
Molecular endocrinology (Baltimore, Md.) 1999;13(5):787-96.
1999: Susan G Hilsenbeck; WE Friedrichs; Rachel Schiff; Peter O'Connell; Rhonda K Hansen; C Kent Osborne; Suzanne A W Fuqua
Statistical analysis of array expression data as applied to the problem of tamoxifen resistance.
Journal of the National Cancer Institute 1999;91(5):453-9.
1999: Sami Diab; Susan G Hilsenbeck; Elzbieta Izbicka; Steven D Weitman; Daniel Von Hoff
Significant activity of a novel cytotoxic agent, LY295501, against a wide range of tumors in the human tumor cloning system.
Anti-cancer drugs 1999;10(3):303-7.
1999: Carolyn D Britten; Susan G Hilsenbeck; S Gail Eckhardt; Jennifer Marty; Gina L Mangold; John R MacDonald; Eric K Rowinsky; Daniel Von Hoff; Steven D Weitman
Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model.
Cancer research 1999;59(5):1049-53.
1999: Carolyn D Britten; Elzbieta Izbicka; Susan G Hilsenbeck; R Lawrence; K Davidson; Cesario Cerna; Lionel Gomez; Eric K Rowinsky; Steven D Weitman; Daniel Von Hoff
Activity of the multitargeted antifolate LY231514 in the human tumor cloning assay.
Cancer chemotherapy and pharmacology 1999;44(2):105-10.
1999: Steven D Weitman; Gina L Mangold; Jennifer Marty; D Dexter; Susan G Hilsenbeck; J Rake; P Juniewicz; Daniel Von Hoff
Evidence of enhanced in vivo activity using tirapazamine with paclitaxel and paraplatin regimens against the MV-522 human lung cancer xenograft.
Cancer chemotherapy and pharmacology 1999;43(5):402-8.
1998: Sami Diab; Susan G Hilsenbeck; CA de Moor; Gary M Clark; C Kent Osborne; Peter M Ravdin; Richard M Elledge
Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1655-60.
1998: C Kent Osborne; Richard M Elledge; P H Brown; Susan G Hilsenbeck
BRCA1 in clinical breast cancer.
Breast disease 1998;10(1-2):77-88.
1998: Gladys I Rodriguez; John Kuhn; Geoffrey R Weiss; Susan G Hilsenbeck; John R Eckardt; A Thurman; David A Rinaldi; S Hodges; Daniel Von Hoff; Eric K Rowinsky
A bioavailability and pharmacokinetic study of oral and intravenous hydroxyurea.
Blood 1998;91(5):1533-41.
1998: Adrian V Lee; Susan G Hilsenbeck; D Yee
IGF system components as prognostic markers in breast cancer.
Breast cancer research and treatment 1998;47(3):295-302.
1998: Susan G Hilsenbeck; Peter M Ravdin; CA de Moor; Gary C Chamness; C Kent Osborne; Gary M Clark
Time-dependence of hazard ratios for prognostic factors in primary breast cancer.
Breast cancer research and treatment 1998;52(1-3):227-37.
1998: Gladys I Rodriguez; John Kuhn; Geoffrey Weiss; P De La Cruz; Pamela New; S M Fields; John R Eckardt; L Campbell; G M Clark; Susan G Hilsenbeck; Daniel Von Hoff
A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusion.
Investigational new drugs 1998;16(1):57-67.
1997: Gary M Clark; D Craig Allred; Susan G Hilsenbeck; Gary C Chamness; C Kent Osborne; D Jones; W H Lee
Mitosin (a new proliferation marker) correlates with clinical outcome in node-negative breast cancer.
Cancer research 1997;57(24):5505-8.
1997: Peter M Ravdin; CA de Moor; Susan G Hilsenbeck; M K Samoszuk; P M Vendely; Gary M Clark
Lack of prognostic value of cathepsin D levels for predicting short term outcomes of breast cancer patients.
Cancer letters 1997;116(2):177-83.
1997: C L Van den Berg; G N Cox; C A Stroh; Susan G Hilsenbeck; CN Weng; M J McDermott; D Pratt; C Kent Osborne; EB Coronado-Heinsohn; D Yee
Polyethylene glycol conjugated insulin-like growth factor binding protein-1 (IGFBP-1) inhibits growth of breast cancer in athymic mice.
European journal of cancer (Oxford, England : 1990) 1997;33(7):1108-13.
1997: Sami Diab; Y Y Yu; Susan G Hilsenbeck; D Craig Allred; Richard M Elledge
WAF1/CIP1 protein expression in human breast tumors.
Breast cancer research and treatment 1997;43(2):99-103.
1997: JE Hundley; SK Koester; Dean A Troyer; Susan G Hilsenbeck; RE Barrington; Jolene J Windle
Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors.
Cancer research 1997;57(4):600-3.
1997: JE Hundley; SK Koester; Dean A Troyer; Susan G Hilsenbeck; Mark A Subler; Jolene J Windle
Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53.
Molecular and cellular biology 1997;17(2):723-31.
1997: R L Rocha; Susan G Hilsenbeck; James G Jackson; C L VanDenBerg; C n Weng; Adrian V Lee; D Yee
Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(1):103-9.
1997: J J Sharma; B Razvillas; CD Stephens; Susan G Hilsenbeck; A Sharma; Mace L Rothenberg
Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer.
Investigational new drugs 1997;15(4):361-4.
1996: Steffi Oesterreich; Susan G Hilsenbeck; Daniel R Ciocca; D Craig Allred; Gary M Clark; Gary C Chamness; C Kent Osborne; Suzanne A W Fuqua
The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(7):1199-206.
1996: R L Rocha; Susan G Hilsenbeck; James G Jackson; Adrian V Lee; J A Figueroa; D Yee
Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features.
Journal of the National Cancer Institute 1996;88(9):601-6.
1996: Mace L Rothenberg; John R Eckardt; John Kuhn; Howard A Burris; James Nelson; Susan G Hilsenbeck; Gladys I Rodriguez; A M Thurman; L S Smith; S Gail Eckhardt; G R Weiss; Gary L Elfring; David A Rinaldi; Larry J Schaaf; Daniel Von Hoff
Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1128-35.
1995: Richard M Elledge; S Lock-Lim; D Craig Allred; Susan G Hilsenbeck; L Cordner
p53 mutation and tamoxifen resistance in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(10):1203-8.
1995: C Kent Osborne; E B Coronado-Heinsohn; Susan G Hilsenbeck; B L McCue; A E Wakeling; R A McClelland; DL Manning; R I Nicholson
Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
Journal of the National Cancer Institute 1995;87(10):746-50.
1994: D Yee; J Sharma; Susan G Hilsenbeck
Prognostic significance of insulin-like growth factor-binding protein expression in axillary lymph node-negative breast cancer.
Journal of the National Cancer Institute 1994;86(23):1785-9.
1994: P Pujol; Susan G Hilsenbeck; Gary C Chamness; Richard M Elledge
Rising levels of estrogen receptor in breast cancer over 2 decades.
Cancer 1994;74(5):1601-6.
1994: S E McGuire; Susan G Hilsenbeck; J A Figueroa; James G Jackson; D Yee
Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissues.
Cancer letters 1994;77(1):25-32.
1994: Suzanne A W Fuqua; Steffi Oesterreich; Susan G Hilsenbeck; Daniel Von Hoff; J Eckardt; C Kent Osborne
Heat shock proteins and drug resistance.
Breast cancer research and treatment 1994;32(1):67-71.
1994: Gary M Clark; Susan G Hilsenbeck; Peter M Ravdin; Michele De Laurentiis; C Kent Osborne
Prognostic factors: rationale and methods of analysis and integration.
Breast cancer research and treatment 1994;32(1):105-12.
1993: Mace L Rothenberg; John Kuhn; Howard A Burris; James Nelson; John R Eckardt; M Tristan-Morales; Susan G Hilsenbeck; G R Weiss; L S Smith; Gladys I Rodriguez
Phase I and pharmacokinetic trial of weekly CPT-11.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(11):2194-204.
1993: J A Figueroa; J Sharma; James G Jackson; M J McDermott; Susan G Hilsenbeck; D Yee
Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.
Journal of cellular physiology 1993;157(2):229-36.
1993: Steffi Oesterreich; C N Weng; M Qiu; Susan G Hilsenbeck; C Kent Osborne; Suzanne A W Fuqua
The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines.
Cancer research 1993;53(19):4443-8.
1992: K L Knorr; Susan G Hilsenbeck; C R Wenger; G Pounds; T Oldaker; P Vendely; M R Pandian; D Harrington; Gary M Clark
Making the most of your prognostic factors: presenting a more accurate survival model for breast cancer patients.
Breast cancer research and treatment 1992;22(3):251-62.
1992: Susan G Hilsenbeck; Gary M Clark; W L McGuire
Why do so many prognostic factors fail to pan out?
Breast cancer research and treatment 1992;22(3):197-206.
1992: Peter M Ravdin; Gary M Clark; Susan G Hilsenbeck; M A Owens; P Vendely; M R Pandian; W L McGuire
A demonstration that breast cancer recurrence can be predicted by neural network analysis.
Breast cancer research and treatment 1992;21(1):47-53.